Market Research Blog – Page 9683 – New Product Development

Homecare Dermatology Energy-based Devices Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2028

Growing commercialization of advanced technology in homecare dermatology and frequent introduction of user-friendly dermatology services are collectively boosting the growth prospects for homecare dermatology energy-based devices landscape at a global level.

According to a newly released intelligence report by Future Market Insights, exhibiting nearly 5% year over year growth in revenue, the global homecare dermatology energy-based devices landscape is likely to be worth over US$ 550 Mn in 2020. While maximum incremental opportunity is projected for China and APEC, North America – despite being the global leader – is likely to witness moderate growth in coming years.

Rapidly growing demand for homecare devices as a result of a paradigm shift from conventional clinics to in-house, non-invasive energy treatments is prominently responsible for healthy revenue growth projections for homecare dermatology energy-based devices.

Technological advancements in these devices are widening their application base, thereby pushing the rate of adoption further at a global level. Another strong push factor associated with homecare dermatology energy-based devices includes their availability as the OTC products.

Product type analysis of market landscape reveals that laser and IPL (intense pulsed light) equipment are enjoying the highest sales, whereas LED equipment is projected to emerge as the most attractive segment in homecare dermatology energy based devices space in the near future.
Hair removal and acne, followed by wrinkles treatment, are reportedly the most extensively sought after applications of homecare dermatology energy based devices.
E-commerce dominates all other distribution channels, according to the report. Hyper markets and super markets also remain among the preferred channels for product distribution.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7699

A Bird’s Eye View of the Global Landscape

“The global market for homecare dermatology energy based devices is a highly consolidated landscape, wherein the top two players collectively account for around 60% share of the market revenue. Koninklijke Philips, with more than a third of the market value share, secures the top position with its extensive portfolio of intense pulsed light devices used for hair removal,” explains a senior research analyst while offering the inclusions of the company’s recent report on the global homecare dermatology energy based devices market.

Adding further to the information about the market competition, the analyst says, “A majority of companies are prioritizing product innovations in LED, IR, and lasers segments. Moreover, a large number of market players are taking efforts for extended product reach through retail partnerships, in addition to NPD for a wider application base. Companies are also observed to be focusing on collaborations and acquisitions to reshape their product distribution strategy for better profitability”.

FDA Approvals Are Relatively Easy

Relatively easy and faster FDA approvals for homecare dermatology energy based devices are driving improved appearance of these devices in tandem with the latest handheld gadgets, which prominently curtail the need for frequent visits to professional cosmetic treatment centers.

A recent example includes FDA clearance for Titan – the anti-aging device launched by Skinovations Inc. later in 2017.

On a similar line, North American and European markets for homecare dermatology energy based devices are witnessing remarkable adoption in recent years. FMI identifies a slew of business expansion opportunities in the aforementioned regions for manufacturers of homecare dermatology energy based devices.

Moreover, growing R&D efforts as manufacturers in the US zoom in on the production quality, is likely to shape the performance of North America’s market for homecare dermatology energy based devices.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7699

Combination of Technologies for Better Treatment Output

Making the most of the best attributes of LED and lasers technologies, a new trend among manufacturers now involves the combination of both the technologies for manufacturing homecare dermatology energy based devices. While these devices are claimed to be effectively reducing fine lines and improving skin tone with LED, lasers enable them to be highly target specific. A recent example is of YA-MAN’s RF Beaute Photo PLUS.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Endoscopy Fluid Management Systems Market to attain an projected worth of US$ 683 Million by 2028.

[187 Pages Report] According to the FMI study, as the Tier 1 players continue to contribute over 70% share of the market revenue, the global endoscopy fluid management systems landscape remains a highly consolidated space.

Providing a brief overview of the FDA regulations for Class II medical devices such as endoscopes, a new study presented by Future Market Insights offers an exhaustive assessment of the global endoscopy fluid management systems landscape for a 10-year projection period, 2018-2028.

The report covers extensive profiling of the top four performers including a few of the biggest industry names such as Stryker Corporation and Olympus Corporation. However, research indicates that even local players have strong penetration in regional markets.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4358

Top 3 Insights from Key Players Analysis

While a majority of companies are focusing on new product launches, strategic mergers and acquisitions are likely to emerge the most profitable developmental decisions in the near future. Most of these strategic moves will be primarily directed to address the high price point pressure associated with endoscopy fluid management systems that often affects revenue growth in developing economies. Major hospital networks in developed regional markets are witnessing M&A between hospitals, which is likely to shape costing of medical devices such as endoscopy fluid management systems – eventually slashing down the profitability margins of manufacturers. “Constantly increasing chronic disease instances, coupled with immense technological advances in the field of endoscopy, is prominently driving the US$ 342 Million market for endoscopy fluid management systems (or irrigation pumps) in recent years,” says a senior research analyst at the company.

Prominent Players:

Karl Storz GmbH & Co KG
Olympus Corporation
Richard Wolf GmbH
Smith & Nephew
Stryker Corporation
DePuy Synthes (Johnson & Johnson Services Inc.)
Cantel Medical Corporation
Medtronics Plc.
B. Braun Medical Inc. and Hologic Inc

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-4358

Top 5 Insights from Segmental Analysis

With maximum use in laparoscopic procedures, endoscopy fluid management systems continue to register maximum revenue generation through sales of laparoscopy suction irrigation pumps, followed by laparoscopy fluid management systems.

Based on the modality of endoscopy fluid management systems, the Benchtop holds a substantial market value share.

Hospitals register the highest consumption of endoscopy fluid management systems.

Owing to a massive number of cancer survivors in the US, North America’s market for endoscopy fluid management systems is currently accounting for the largest revenue share in the global landscape, followed by Asia Pacific and Europe.

MEA and Latin America are likely to represent a significant incremental opportunity, according to FMI study.

Healthy Year over Year Revenue Growth Projected for Asia Pacific

APAC has become the hotspot for leading medical device companies, which is further intensified by dramatically growing medical tourism sector. Across APAC, Japan is likely to account for substantial revenue generation, enabling the regional market secure second spot in the global endoscopy fluid management systems landscape. FMI projects over 7% year on year revenue growth in 2020 and beyond, for this regional market.

Government Regulations Favor Market Growth in Latin America

Latin American market for endoscopy fluid management systems is thriving at a promising pace owing to favorable government initiatives regarding endoscopic procedures and medical device marketing. Noteworthy demand for laparoscopy suction irrigation pumps within the region is identified to be responsible for the rapid revenue growth of endoscopy fluid management systems marketplace across Latin America.

Egypt’s End Users Drive Market Growth in MEA

The market for endoscopy fluid management systems in MEA is prominently driven by the improving regulatory landscape related to the marketing of medical devices, pushed further by impressive sales of laparoscopy suction irrigation pump based endoscopy fluid management systems. FMI spots higher market attractiveness in Egypt owing to the presence of a large number of end users. However, poor operational environment still remains a major growth barrier for the region.

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/4358

Segmentation

The report offers a comprehensive taxonomy of the endoscopy fluid management systems market based on product type, end user, modality and region. Endoscopy fluid management systems are used for various types of endoscopic surgeries such as hysteroscopy and laparoscopy.. End-user segments in the endoscopy fluid management systems market include hospitals, ambulatory surgical centers and other end users, such as specialty clinics & diagnostic centers.

From a regional perspective, the endoscopy fluid management systems market has been analyzed across North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

About FMI:

Cell Line Development Market size is projected to account for over US$ 7,200 Million, in terms of value, by 2028 end

[329 Pages Report] According to a latest research by Future Market Insights (FMI), the global cell line development market size is anticipated to account for over US$ 7,200 Mn, in terms of value, by 2028 end. The report on cell line development market further projects significant growth potential with CAGR at 7.2% through 2028.

According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research. Cell lines are projected to be used for development of new treatment pathway for various disease including cancer and neurological diseases.

Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient treatment pathway. Companies and government organizations are investing on research and development activities and are also focusing more on cell line development in search of new cellular pathway to develop novel drugs. The increased spending on biosimilar R&D from exiting biopharmaceutical companies would provide boost to cell line development market.

In recent time the contract research organizations are focusing on cell line development and cell line research activities. According to National Institutes of Health (NIH) the estimated total federal spending on all type of stem cell line research for 2017 is US$ 1.58 Bn. In developing countries like India, government is supporting cell line development through national funding agencies like Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Department of Science and Technology (DST).

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7566

Regenerative medicines are the next generation treatment solution and Cell Line Development or Cell Culture is a vital part for regenerative medicine. Increasing demand of regenerative medicines in cancer treatment would positively impacting the growth of Cell Line Development market over the forecast period.

The biopharmaceutical companies operating in development of novel drug line are expected to hold promising revenue opportunity in cell line development market.

Future Market Insights (FMI) has segmented the cell line development market based on product type, cell line source type, end user, type of cell line and region.

Product type segment in cell line development market is segmented into media and reagents, equipment and accessories. Reagents and Media are required from incubation to preservation of cell lines. These products are expensive and have repetitive use in cell culture or bio-production. Reagent and media segment in cell line development market is expected witness noteworthy growth in terms of revenue owing to rapid increase in demand in cell culture and cell based assays.

Cell line development market by cell line source is categorized into mammalian cells and non-mammalian cells. Mammalian cell line development is anticipate to witness significant growth in overall cell line development market. This growth of mammalian cells segment in cell line development market is driven by increased production of biologics drugs which require mammalian cells. Increasing antibody production is the major driving factor behind the growth of mammalian cell lines segment in cell line development market.

Mammalian cell lines are used to create therapeutic proteins through genetic building and antibodies through viral infection. For example, Gaucher’s disease, which is a genetic disorder characterized by lack of β-glucocerebrosidase enzyme and can be treated by Cerezyme which is a recombinant enzyme produces in mammalian cell lines. Mammalian cell lines are also useful in production of antibodies and other therapeutic agents such as specific binding proteins that can neutralize disease causing agents in the body. For example Under cell line type segment in cell line development market, recombinant cell line development are the most demanding type of cell line due to large application in biologics production, protein interaction, gene activation, toxicity testing and drug screening.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7566

Growing application recombinant cell line development in drug toxicity testing is expected to boost the growth of overall cell line development during the forecast period

North America and Europe cell line development market will dominate in owing to increasing government funding in cell line development research and rising spending on biosimilar developments. Asia Pacific cell line development market is expected to grow at a high growth rate due to increased number of research organization engaged in novel biologics and biosimilar fastest revenue growth in overall cell line development market.

The Asia Pacific region in Cell line development market is anticipate to witness increasing demand of biopharmaceuticals and regenerative medicines are expected to boost the growth of the cell line development market.

FMI’s report tracks some of the key companies operating in the cell line development market, such as Selexis SA, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., American Type Culture Collection (ATCC), Lonza (Sartorius Stedim Biotech S.A.), Danaher Corporation, Merck KGaA, WuXi Biologics.

Key Market Segments Covered in Cell line development Market Research By Product Type:

Reagent and Media
Equipment
Accessories and consumables

By Source Type:

Mammalian cell line
Non-mammalian cell line

By End User:

Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Biotechnology Companies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7566

By Cell Lines:

Recombinant cell lines
Hybridomas
Continuous cell lines
Primary cell lines

By Region:

North America
Latin America
Europe
CIS & Russia
Japan
APEJ
MEA

About FMI:

Pharma Grade Synthetic Camphor Market is expected to register the growth of 4.2% CAGR from 2022 to 2028

[253 Pages Report] According to the latest research by the company, the global pharma-grade synthetic camphor market size is anticipated to be valued at US$ 532.0 Mn, by 2028 end.

The report on pharma-grade synthetic camphor market further projects significant growth potential with average year-on-year growth rate pegged at 4.1% through 2028.

Growing demand for topical pain management products is expected to propel the growth of pharma-grade synthetic camphor market. Pharma-grade synthetic camphor is used in many topical analgesic products such as oils, ointments, chest rubs, and gel.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7564

These pharma-grade synthetic camphor pain management products are experiencing significant growth due to lesser side effect compare to oral analgesic and expanded retail channel access. Increasing self-medication rate and availability of cost-effective camphor contained OTC analgesic favors the growth of pharma-grade synthetic camphor market growth.

pharma grade synthetic camphor market

Growing incidence of infectious diseases such as cold, flu augmented the use of cold sore remedies, nasal decongestants, topical expectorants etc. which in turn would drive the growth of pharma-grade synthetic camphor market. Increasing use of private labeled topical products containing camphor push the demand for pharma-grade synthetic camphor.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7564

Private label analgesic is gaining popularity in the U.S. market as they do not require FDA approval and strong promotion activities by retailers. Walgreens Ultra Strength Muscle Rub (4% camphor), Salonpas pain relieving patch (1.2% camphor) are the examples of private label analgesic which contain camphor. Surge in commodity export, economic growth and production capacity are expected to boost the growth of pharma-grade synthetic camphor market.

However, regulatory restrictions on the use of camphor in the medicine of pharmaceutical products would considerably impact the growth of pharma-grade synthetic camphor market. Moreover, increasing raw material prices are expected to hamper the growth of pharma-grade synthetic camphor market. Thus, growing prices of raw materials i.e. alpha pinene or turpentine oil is a major challenge for the manufacturers of pharma-grade synthetic camphor.

Company has segmented the global pharma-grade synthetic camphor market into formulation, application, distribution, and regions. Based on the formulation, pharma-grade synthetic camphor market is segmented into topical and inhalation. The topical segment is expected to represent a highest revenue share in pharma-grade synthetic camphor market as high number of marketed products and vast applications. Applications of pharma-grade synthetic camphor included in the report are respiratory disorders applications, muscular rheumatism, counterirritant & antipruritic and others (topical analgesic, cold sores, minor burns, antifungal, hemorrhoids, topical antitussive & expectorant, astringent, rubefacient, etc.). Others segment expected to contributes highest market value in global pharma-grade synthetic camphor market. Based on the distribution channel, pharma-grade synthetic camphor market is segmented into conventional B2B and online B2B channel. In terms of revenue, conventional B2B segment would hold significant revenue share in pharma-grade synthetic camphor market over the forecast period.

On the basis of region, the global pharma-grade synthetic camphor market has been segmented into North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding China & Japan, China, Japan, and the Middle East & Africa. North America is expected to contribute highest revenue share in global pharma-grade synthetic camphor market. The demand of pharma-grade synthetic camphor has increased in North America, as increasing production of camphor contained private label and OTC products. China is expected to witness the highest growth rate in pharma-grade synthetic camphor market due to presence of the larger number of pharma-grade synthetic camphor manufactures. Pharma-grade synthetic camphor manufactures are mainly concentrated in China and India and they export their chemicals to the U.S. and Europe. Moreover, due to its growing contribution to the global industry, Asia Pacific is emerging as a focused destination for global manufacturers of camphor and related chemicals.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/7564

Report tracks some of the key companies operating in the global pharma-grade synthetic camphor market. Representative players included in the global pharma-grade synthetic camphor market report are Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation, Prinova Group LLC. and Fengchen Group Co., Ltd. Manufactures are focusing on improvement of the supply chain which expected to provide huge opportunities to them over the forecast period.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Next Generation Optical Biometry Devices Market to reach US$ 461.3 Million by 2028

Increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals globally are factors increasing the adoption of next generation optical biometry devices.

With the advancement in the technology, next generation optical biometry devices have been developed aiding measurement of eyes before cataract and refractive surgeries. Earlier measurement by ultrasound technique was gold standard. However, unlike next generation optical biometry devices, ultrasound devices require direct contact of the probe, which lead to many eye infections.

The next generation optical biometry devices are automated and measure many parameters such as the axial length, anterior chamber depth, thickness of the lens, retinal thickness, pupil size and many more.

The next generation optical biometry devices are an accurate alternative for the precise measurements and provide efficient results. Also the next generation optical biometry devices avoid the operator variations measurements.

Research indicates next generation optical biometry devices market is anticipated to account for revenues over US$ 450 Mn, by 2028 end. The report on next generation optical biometry devices projects market revenues to expand at a CAGR of 5.1% through 2028.

According to Prevent Blindness organization, ~25 Mn Americans having cataract require medical care every year in the U.S., hence boosting demand for next generation optical biometry devices.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7556

Similar rising demand for next generation optical biometry devices is noted in UK with rising number of cataract surgeries. Increased demand for next generation optical biometry devices is noted in developing markets concurrent with access to eye care facilities.

Next generation optical biometry devices are all-in one devices used for evaluation of lens and refraction, of retina.

Next Generation Optical Biometry Devices Market: Overview & Analysis

Rapid increase in number of probe infections due to usage of ultrasound devices, lead to post-operative errors fuelling demand for next generation optical biometry devices instead of ultrasound biometry devices.

Manufacturers of next generation optical biometry devices are introducing automated devices which are more efficient in measuring segments of eyes. Players in next generation optical biometry devices market are working on strengthening the software, which could provide detailed information about eye segments.

New next generation optical biometry devices introduced are taking into account irregularities and astigmatisms of the anterior and the posterior surfaces of the eye.

The next generation optical biometry devices uses a partially coherent wave that has approximately 9x the resolution of a 10 MHz sound wave, for precise measurement of axial length.

Hospitals end users segment account for 41.8% revenue share in the global Next Generation Optical biometry Devices market. Medical services and vision benefits offered under Medicare includes cataract surgeries; which will increase the demand of next generation optical biometry devices.

Increasing geriatric population and rising income in Japan is expected to surge the demand for more advanced Next Generation Optical biometry Devices. Japan Next Generation Optical biometry Devices market is estimated to create absolute $ opportunity worth approximately US$ 1.21 Mn between 2017 and 2028.

The company has segmented the global Next Generation Optical Biometry Devices Market into product type and end users. In terms of revenue, the swept source segment in product type in next generation optical biometry devices market report will account for significant revenue share over the forecast period.

In contrary, the Partial coherence interferometry (PCI) based next generation optical biometry devices segment in all the markets will exhibit limited investment opportunities through 2028 in next generation optical biometry devices market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7556

Next Generation Optical Biometry Devices Market: Key PlayersThe next generation optical biometry devices market report tracks some of the key companies, such as Carl Zeiss AG, Nidek Co Ltd, Haag-Streit AG(Metall Zug AG), Ziemer Ophthalmic Systems, Optovue, Incorporated, Topcon Corporation, TOMEY GmbH, Movu Inc. (unit of Santec Corporation) , Newway Technology and OCULUS Optikgeräte GmbH. The largest player in the next generation optical biometry devices market is Carl Zeiss AG with its IOL masters and Haag-Streit AG’s Lenstar.

Key Segments of Next Generation Optical Biometry Devices Industry SurveyNext Generation Optical Biometry Devices Market by Product Type

Swept-Source Optical Coherence Tomography (OCT) Based Biometers
Partial Coherence Interferometry (PCI) Based Biometers
Optical Low Coherence Reflectometry (OLCR) Based Biometers

Next Generation Optical Biometry Devices Market by End User

Hospitals
Ophthalmology Clinics and Specialized Eye Care Centers
Ambulatory Surgical Centers

About FMI:

Preterm Birth Diagnostic Test Kits Market to reach a value of over US$ 200 Million by 2028

A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028’, has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the preterm birth diagnostic test kits market.

The global preterm birth diagnostic test kits market is expected to expand at a CAGR of 7.4% over the forecast period to reach a value of over US$ 200 Mn by 2028, and the North America preterm birth diagnostic test kits market is expected to remain as a main sink market for revenues. Europe is expected to remain as the main source market for preterm birth diagnostic test kits, as most of the preterm birth diagnostic test kits facilities are located in this region. However, with the increasing demand and cost-effective diagnostic options in countries such as China and India, and various countries of Asia Pacific and Middle-East, is fueling the growth of preterm birth diagnostic test kits market.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7551

Key Findings Presented in the Report on the Preterm Birth Diagnostic Test Kits Market

The report finds that approximately 115.4 million births occurred in 2017, out of which 11.1% births were preterm, which is approximately 12.8 million births. As per WHO, preterm birth complications are the leading cause of deaths amongst children under the age of 5, directly responsible for approximately 1 million death in 2015. Out of these, 3/4th of these deaths can be prevented with cost-effective interventions. The adoption rates for preterm birth diagnostic tests kits ranged from 2% to 15% distributed over various geographies. Majority of the existent patient pool are unaware about the cost-saving benefits of preterm birth diagnostic test kits, thus, a major portion on the preterm birth test kits market has remained untapped which remains open for manufactures of preterm diagnostic test kits to exploit the preterm birth diagnostic test kits market over the forecast period.

Analysis of the Preterm Birth Diagnostic Test Kits Market

For preterm birth diagnostic test kits, blood sample is the most common sample take for diagnosing preterm labor and premature rupture of membrane. Blood sample-based preterm birth diagnostic tests in preterm cases are the most common and widely accepted in the preterm birth diagnostic test kits end users. However, vaginal discharge sample type preterm birth diagnostic tests are gaining popularity for preterm birth diagnostic test kits.

Hospitals, outpatient clinics & diagnostic laboratories using preterm birth diagnostic tests are the primary point of contact for patients experiencing preterm birth symptoms. Hospitals are estimated to account for majority of the revenue share under the end users segment for preterm birth diagnostic test kits market in 2017, owing to being the primary healthcare facility for preterm cases. The prevalent cases of preterm birth, growing demand for cost-effective diagnostic options and preterm birth test kits, and success in clinical studies for developing a rapid preterm birth diagnostic test kits is expected to fuel the growth of the global preterm birth diagnostic test kits market over the forecast period.

Activities across the preterm birth diagnostic test kits manufacturers are restricted to efficiency and specificity testing. The top activity associated with preterm birth diagnostic test kits manufacturers is joint collaboration with various organizations in order to spread awareness, further development, and test the sensitivity, specificity and efficiency of preterm birth diagnostic test kits.

Preview Analysis On Preterm Birth Diagnostic Test Kits Market Segmenatation By Product Type – Fetal Fibronectin Test Kits (fFN), Placental Alpha Micro-globulin-1 test kits (PAMG-1), Binding Protein-1 test kits (IGFBP-1); Sample Type – Blood sample, urine sample, and vaginal discharge sample

Factors Impacting Growth of the Preterm Birth Diagnostic Test Kits Market

Rising focus on cost-effective diagnosis using preterm birth diagnostic test kits is expected to boost the growth of the preterm birth diagnostic test kits market. Preterm birth diagnostic test kits manufacturing companies focusing on spreading awareness about preterm birth diagnostic test kits and marketing preterm birth diagnostic test kits through campaigns and joint research studies is expected fuel the growth of the preterm birth diagnostic test kits market during the forecast period. However, Preterm birth diagnostic kits experience stiff competition from alternative product lines. Trans-vaginal scans, advanced ultrasound are some of the examinations adopted by healthcare providers over preterm birth diagnostic kits and would pose challenges to the growth of the preterm birth diagnostic test kits market.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/7551

Preterm Birth Diagnostic Test Kits Market: Companies

Some of the key preterm birth diagnostic test kits companies analyzed in this report titled Preterm birth diagnostic test kits market include Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products, Biosynex, Nanjing Liming Biological Preparations Co Ltd, Clinical Innovations LLC, BIOSERV Diagnostics GmbH, Wuxi BioHermes Biomedical Technology Co. Ltd, and Anhui Deep Blue Medical Technology.

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Actinic Keratosis Treatment Market Key Players : Sun Pharmaceutical Ltd., Nestle SA, Novartis AG GlaxoSmithKline Plc., Leo Pharma Inc. etc.

[275 Pages Report] Global demand for actinic keratosis treatment, majorly driven by that in the U.S. and European countries, continues to grow at a strong rate. Poised for revenues of over US$ 4 Bn by the end of 2019, the global actinic keratosis treatment market will exhibit an impressive CAGR of 7% during the forecast period (2019 – 2029).

The understanding about the nature of actinic keratosis and the potential risk of this condition progressing to squamous cell carcinoma (SCC) is improving, among patients as well as healthcare providers. Especially among the elderly, actinic keratosis remains one of the most commonly diagnosed dermatological condition that creates a continued need for efficacious treatments.

Who Is Winning?

The actinic keratosis treatment market report tracks the key market players, which includes GlaxoSmithKline Plc. Nestle SA, Novartis AG, Sun Pharmaceutical Ltd., Leo Pharma Inc. etc. Leading manufacturers in the actinic keratosis treatment market are focusing on acquisitions to enhance their product portfolio. For instance, in November 2015, Leo Pharma A/S completed the acquisition of dermatology business of Astellas Pharma. With this acquisition, the company expanded its dermatology product portfolio segment. Companies are also focusing on segment leadership. In February 2016, Cipher Pharmaceuticals Inc. launched Actikerall for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis to mark their leadership in topical product segment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3233

Combination therapies such as topical fluorouracil cryotherapy, PDT and imiquimod therapy, chemical peels, and 5-FU are generally the most prescribed therapies for actinic keratosis. Convenient administration, lower potential for irritation, and systemic absorption continue to underpin their high adoption rate. Development of drugs with increased efficacy and decreased side effects that can be used as combination therapy for actinic keratosis treatment is currently the focal point of global market leaders. Biofrontera AG commercially launched its product Ameluz (2016), used in combination with PDT for actinic keratosis treatment.

Development of minimally invasive drug-device combination therapies and fast track regulatory approval for pipeline drugs will be offering a completely new set of treatment options for actinic keratosis in the near future.

Key Takeaways – Actinic Keratosis Treatment Market Study

Growing use of topical products as the first-line preference for actinic keratosis treatment is offering huge opportunities to market players to develop and launch new topical products for actinic keratosis treatment.
Increasing collaboration activities by key market players of the actinic keratosis treatment market with other companies to broaden their products portfolio is anticipated to propel the actinic keratosis treatment market growth.
- For instance, in March 2017, Galderma SA (Nestle Skin Health Company) collaborated with Colorescience, to enhance its product portfolio for aesthetic treatment.
Increasing product approvals of actinic keratosis treatment by regulatory bodies is expected to fuel the actinic keratosis treatment market growth.
- For instance, in March 2018, combination of Ameluz and daylight photodynamic therapy (PDT) by Biofrontera AG got approval from the European Union.
The U.S. and Australia marking rise in incidence and prevalence of actinic keratosis will remain highly prominent markets for actinic keratosis treatment providers.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on actinic keratosis treatment market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 on the basis of treatment category (topical treatment, procedural modality, photodynamic therapy and others), disease type (clinical AK and subclinical AK)and end-user (hospitals, laser therapy centers, private dermatology clinics, spas and rejuvenation centers, cancer treatment centers, homecare) in seven key regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3233

Actinic Keratosis Treatment Market By Category

By Treatment Type:

Topical Treatment
- 5-fluorouracil Cream
- Diclofenac Gel
- Imiquimod Cream
- Ingenol mebutate Gel
Procedural Modality
- Chemical Peels
- Cryotherapy
Photodynamic Therapy
Others

By Disease Type:

Clinical AK
Subclinical AK

By End User:

Hospitals
Private Dermatology Clinics
Laser Therapy Centers
Cancer Treatment Centers
Spas and Rejuvenation Centers
Homecare

About FMI:

In-ear-monitors (IEMs) Market to reach a valuation of ~US$ 749.7 Mn by the year 2032 | FMI

[335 Pages Report] The global in-ear-monitors (IEMs) market is poised to grow lucratively with its advanced features and popularity. Despite the Coronavirus, the global sale of in-ear-monitors (IEMs) market remains untouched by the economic adversities. The lockdown and self-isolation surged the sale of in-ear-monitors with their delivery aided by online retailers.

Outstanding Features of In-ear monitors (IEMs) such as ease, improved connectivity, signal transmission, noise cancellations and decreased dependencies on sound engineers for audio mixing, fuels the in-ear-monitors (IEMs) market growth.

In-ear-monitors (IEMs) Market study by “Future Market Insights” provides details about the market dynamics affecting the market, Covid-19 Impact, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.

Get a Sample Copy of Report – https://www.futuremarketinsights.com/reports/sample/rep-gb-12569

This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.

The report In-ear-monitors (IEMs) Market gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments. It also provides the market size and estimates a forecast from the year 2018 to 2028 with respect to major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the In-ear-monitors (IEMs) Market.

The report facilitates in determining and interpreting the key market players, portfolios with necessary information such as company profiles, components and services offered, financial information of past few years, key developments in past few years, that helps in constructing strategies to gain competitive advantage in the long run. The report also analyzes factors affecting In-ear-monitors (IEMs) Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12569

Leading In-ear-monitors (IEMs) Market Players:

Shure
Audio-Technica
LD Systems
Mee audio
Sennheiser
HARMAN International
Samsung
Nady Systems
Hear Technologies
Pyle Audio
Sensaphonics

Key Elements that the report acknowledges:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

Request Table of Content for this Insight – https://www.futuremarketinsights.com/toc/rep-gb-12569

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

In-ear-monitors (IEMs) market

The global in-ear-monitors (IEMs) market is segmented into product type, applications, distribution channels and regions

Product Type:

Wireless
Wired

Applications:

Live Events and Performances
Studio and Broadcasting
Large Venues
Others

Distribution Channels:

Retailers and supermarket
Online

More Trending Reports by Future Market Research :

Pharmacy Refrigerators Market : The global pharmacy refrigerators market is estimated to be valued US$ 552.3 million in 2022, rising to US$ 1,027 million by 2032 with a CAGR of 5.8 percent during the forecast period.

Veterinary Services Market : According to FMI, the global veterinary servicesmarket in 2021 was worth US$ 102.3 Billion. The estimated market growth rate from 2022 to 2032 is 8.4%, which is much greater than the historical rate.

X-Ray Device Market : Global demand for x-ray devices is expected to rise at a yearly growth rate of 7.5% Y-o-Y to US$ 24.4 Billion in 2032

About FMI:

Safety Needles Market valuation in excess of US$ 2,500 Million by 2027 | FMI

[277 Pages Report] The global safety needles market was worth $5,123 million in 2021 and is expected to grow at a 7.6% CAGR during the forecast period (2022-2032). In terms of end users, hospital pharmacies are expected to lead the global safety needles market by 2021, with a total valuation of approximately US$ 2.6 billion. By the end of 2032, the global market is expected to be worth US$ 11,370 Mn.

Rising Focus on Use of Prefilled Syringes Fuelling the Demand

At present, value of the global safety needles market is estimated to be s worth US$ 3,752.2 Mn, and it is estimated to reach US$ 7,765.7 Mn by 2027-end, witnessing a CAGR of 6.9% during this forecast period. The growing focus on utilization of prefilled syringes for treatment of several ailments is fuelling the demand for safety needles across the globe. Factors such as changing lifestyle habits, exposure to hormones and infection by HCV are expected to result in gynaecological cancers. Rising incidence rate of gynaecological cancers, coupled with higher presence of lower-back problems in regions such as the US are driving the demand for spine needles and other types of safety needles.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2029

Safety Needles Market

The sole purpose of designing safety needles was to avoid needlestick injuries while collecting fluids and delivering drugs to the body. The key players of global market for safety needles are enhancing their product portfolio by focusing on production of innovative needles with safety features. These players include B. Braun Melsungen AG, Novo Nordisk A/S, Medtronic, and Becton, Dickinson and Company. Becton, Dickinson and Company holds its dominance in the overall market with around 50% share, followed by Medtronic and Novo Nordisk AS. Future Market Insights’ recent report profiles Smith Medical and Argon medical Inc. as emerging safety needle manufacturers, while Terumo Medical Corporation and Boston Scientific Inc. are recognised as mid-level players in the global safety needles market.

Trends Observed in the Global Safety Needles Market

Leading companies are participating in campaigns in co-ordination with governments of several economies for raising awareness about unsafe use of reusable needles among patients. Increasing prevalence of HIV & blood-borne diseases, owing to needle injuries, has also urged the companies for development of needles with enhanced safety features.

Key findings from FMI’s Report Include

Hypodermic needles, as a product, will dominate the market, and is expected to account for 18.1% share during the forecast period. However, biopsy needles are expected to witness fastest revenue growth at 8.6% CAGR.
Hospital pharmacies are estimated to account for more than half of safety needles being distributed globally, while private clinics are expected to garner over US$ 1,300 Mn through 2027.
Drug delivery application of safety needles is expected to gain 242 BPS in its market share. In addition, sample collection is projected to create an absolute $ opportunity of around US$ 1,840 Mn in 2017 over 2016.

APEJ – Fastest-Growing Safety Needles Market in World

Around 24% market share is estimated to be held by Western Europe by the end of 2027, while APEJ is expected to register fastest growth in the global market for safety needles. In contrast, Eastern Europe is poised to depict a sluggish growth during the forecast period, while North America is will remain the outright dominant region in the global market for safety needles.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2029

Market segmentationProduct Type

Fine Aspirating Needles
Biopsy Needles
Hypodermic Needles
Pen Needles
Suture Needles
IV Catheter Needles
Blood Collection Needles
Spinal Anesthesia and Epidural Needles
Prefilled Needles
A.V. Fistula Needles
Cannula Needles
Huber Needles

Application

Sample Collection
Drug Delivery

Distribution Channel

Hospital Pharmacies
Private Clinics
Retail Pharmacies and Drug Stores
E-Commerce

About FMI:

Autoclaves Market is estimated to be valued at US$ 2.09 Bn in 2022 and is expected to reach US$ 3.17 Bn by 2030

[304 Pages] The global autoclaves market will exhibit 5% CAGR between 2020 and 2030, especially as demand for sterilization and disinfections continue rising across hospitals, academic and research institutes, biopharmaceutical companies, and other facilities, finds Future Market Insights (FMI) in a new study. As per the report, increasing cases of hospital acquired infections will encourage investment in autoclaves across healthcare facilities.

According to the Centers for Disease Control and Prevention (CDC), on any given day, about 1 in 31 hospital patients has at least one health-care associated infection. Autoclaving destroys microorganisms with higher efficiency than dry heat. Hence autoclaves are registering increasing applications in the healthcare industry.

While the outbreak of novel coronavirus has taken a toll on the market affecting its growth, it is recovering steadily to bounce back. Patient admissions in hospitals and other healthcare facilities has increased, which is in turn fuelling the demand for autoclaves in the recent year.

FMI offers an in-depth analysis and overview of the global autoclaves market, covering factors enabling its growth, creating prospects, and key threats.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-12890
Some of the key takeaways from the report are highlighted below-

Rise in demand for gravity autoclaves is projected to fuel the growth of the market during the forecast period between 2020 and 2030
Floor standing autoclaves will gain traction due to the high for laboratory applications
The demand for front loading type autoclave is expected to be higher than top loading and pass through
Cylindrical autoclaves will be highly sought-after among chamber types
Academic and research institutes will continue exhibiting high demand for autoclaves
North America will dominate in the global market followed by Europe

“The rising awareness among the hospital staff, doctors, and patients regarding the hospital acquired infections is spurring the growth of the autoclaves market. The outbreak of COVID-19 pandemic has resulted in unbridled rise in patient pool across hospitals and healthcare centers, increasing the risk of hospital acquired infections. According to the National Centre for Biotechnology Information (NCBI), the risks of Central Line-Associated Bloodstream Infection (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI), and others are higher in COVID-affected patients. This has been fuelling the demand for autoclaves and the trend is expected persist over the next couple of years,” says an FMI analyst.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12890
COVID-19 Impact Analysis

The outbreak of COVID-19 pandemic caused decline in the growth of market earlier this year. The sudden lockdown, coupled with restrictions imposed, had severely affected manufacturing units of the autoclaves. However, autoclaves being an integral part of the sterilization process started experiencing surge in demand soon after getting over the temporary period of lull. The ongoing pandemic has resulted in higher requirement for sterilized and clean environment across healthcare facilities, which is substantially pushing the demand curve for autoclaves upward. As per Medical Product Outsourcing (MPO), autoclaves are staples in the healthcare industry and they are used extensively for high-pressure steam sterilization on various tools and industrial components, especially during COVID-19 pandemic.

According to the World Health Organization (WHO), biosafety levels BSL-2 and BSL-3 are required in order to handle COVID-19 by maintaining clean and safe environment. As laboratory autoclaves are ideal for sterilization of contaminated instruments, waste, laboratory equipment, and others while maintaining these standards, they are highly required in diverse end-user industries starting from pathology laboratories to academic and research institutes.

Who is Winning?

Competition in the global autoclaves market has been rising steadily. In order to strengthen their foothold, market players are focusing their efforts towards exploring and capitalizing on new opportunities. This has resulted in a slew of product launches in the last few years.
For instance, Benchmark Scientific has launched their new range of BIOCLAVE RESEARCH AUTOCLAVES which are designed specifically for laboratory research tools and provide fully automatic services in the current year.

Panasonic Biomedical has launched their new extensive range of laboratory autoclaves such as MLS-3020U, MLS-3751L, MLS-3781L, and others in the recent year.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12890

More Valuable Insights on Autoclaves Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global autoclaves market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product (gravity autoclave, vacuum-induced autoclave), modality (floor standing, bench top, wall mounted, portable), loading type (top loading, front loading, pass through), chamber type (cylindrical, rectangular), end user (hospitals, office based clinics, academics and research institutes, research laboratories, pathology laboratories, biopharmaceutical companies, food and beverage companies), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

About FMI: